Racial and Economic Disparities and Unmet Needs in Patients With Severe Aortic Valvular Disease
1 other identifier
observational
200
1 country
1
Brief Summary
Common barriers to receiving appropriate guideline-driven care for patients with severe aortic stenosis include referral biases by primary care providers (lack of provider education), patient comorbidities (degree of fragility), as well as psychosocial issues and cultural barriers. Additionally, race, ethnicity, socioeconomic status (SES) and education level are shown to be persistent barriers to accessing healthcare services and healthcare systems, creating a significant practice gap between various patient populations. The most recent transcatheter valve therapies (TVT) registry data show that \>94% of TAVR recipients are Caucasian, followed by less than 4% of African-Americans and Hispanics, respectively. There is a critical need to understand the barriers to treatment and care among severe aortic valve disease patients of disparate groups. This study is a multi-center, retrospective and prospective cohort study of patients diagnosed with severe aortic stenosis. Additionally, we will be surveying referring primary care providers, cardiologists and cardiovascular surgeons to assess their current referral practices for patients with severe aortic stenosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 4, 2018
CompletedFirst Submitted
Initial submission to the registry
August 20, 2020
CompletedFirst Posted
Study publicly available on registry
August 25, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2022
CompletedApril 8, 2022
April 1, 2022
4.2 years
August 20, 2020
April 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Patient Mortality
30 days and 1 year
MACE (Major Adverse Cardiac Event)
30 days and 1 year
Secondary Outcomes (1)
Referring physician- related barriers/biases.
through study completion, an average of 1 year
Study Arms (2)
Patients with Severe Aortic Stenosis with Disparities
Patients will complete a survey and their aortic stenosis will be clinically followed at 30 days and one year
Medical Providers with Disparities
Referring primary care providers complete a questionnaire on their referral practices for patients with severe aortic stenosis
Interventions
Patient Questionnaire
Eligibility Criteria
Patients: \- Over 18 years of age with echocardiographic diagnosis of severe, symptomatic AS and intermediate to high surgical risk per Society of Thoracic Surgeons (STS) mortality risk-score who have a disparate condition Providers: \- Referring primary care providers, cardiologists and cardiovascular surgeons at the study sites.
You may qualify if:
- Disparity/Diversity background (either race/ethnicity, low SES (adults with incomes at or below the federal poverty level (family income to poverty ratio, ≤1), language (non-English speaker) or education (≤9 years of education))
- Patient scheduled for transcatheter aortic valve replacement using the Edwards Sapien valve, OR recently implanted with Edwards Sapien valve (up to 1 year post-TAVR)
- Echocardiographic diagnosis of severe, symptomatic AS and intermediate to high surgical risk per Society of Thoracic Surgeons (STS) mortality risk-score
You may not qualify if:
- Age \< 18
- Patients who do not allow their records to be used for research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota, 55407, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mario Goessl, MD, PhD
Minneapolis Heart Institute Foundation
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 20, 2020
First Posted
August 25, 2020
Study Start
June 4, 2018
Primary Completion
August 1, 2022
Study Completion
August 1, 2022
Last Updated
April 8, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share